
Lars Dyrskjøt
@ldyrskjot
Professor @AarhusUni | Vice director ctDNA Research Center | Program Chair IBCN | EAU Scientific Congress Office | GU cancers, biomarkers, liquid biopsies
ID: 3078299762
https://www.moma.dk/research/bladder-cancer 13-03-2015 21:57:11
600 Tweet
1,1K Followers
766 Following

Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by Jørgen Bjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples. Key findings: •CtDNA-negative
